Shannon W Finks

发表

Dual Antiplatelet Therapy for Long-Term Secondary Prevention of Atherosclerotic Cardiovascular Events.

P. Dobesh, Shannon W Finks, T. Trujillo, 2020, Clinical therapeutics.

Annual Influenza Vaccination: Offering Protection Beyond Infection

Shannon W Finks, S. Foster, K. C. Rogers, 2012, Southern medical journal.

Edoxaban: How Does the Newest Agent Fit into the DOAC Landscape?

Shannon W Finks, Caitlin M. Gibson, Shannon W. Finks, 2017, The American journal of medicine.

A New Option for Reversing the Anticoagulant Effect of Factor Xa Inhibitors: Andexanet Alfa (ANDEXXA).

Shannon W Finks, K. C. Rogers, Shannon W. Finks, 2019, The American journal of medicine.

Reversal Agents for Direct Oral Anticoagulants: Understanding New and Upcoming Options

Shannon W Finks, K. C. Rogers, Melanie P Shelton, 2016, Cardiology in review.

Management of Venous Thromboembolism

P. Dobesh, Shannon W Finks, T. Trujillo, 2016, The Annals of pharmacotherapy.

Duration of triple antithrombotic therapy and outcomes among patients undergoing percutaneous coronary intervention.

Shannon W Finks, R. Shah, Glenda Delgado, 2017, Cardiovascular diagnosis and therapy.

Heparin Versus Bivalirudin Monotherapy in the Setting of Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction

Shannon W Finks, K. Faulkenberg, Janna C. Beavers, 2016, The Annals of pharmacotherapy.

Re-examining the cardiovascular therapeutic benefits of aspirin.

Shannon W Finks, Shannon W. Finks, 2008, Southern medical journal.

Clinical Efficacy and Safety of Cilostazol: A Critical Review of the Literature

Shannon W Finks, K. C. Rogers, Carrie S Oliphant, 2015, Drugs.

Hydralazine-induced Lupus: Maintaining Vigilance with Increased Use in Patients with Heart Failure

Shannon W Finks, T. Self, A. Finks, 2006, Southern medical journal.

Life-Threatening ACE Inhibitor-Induced Angioedema After Eleven Years on Lisinopril

Shannon W Finks, J. L. Norman, Whitney L Holmes, 2013, Journal of pharmacy practice.

Use of Cilostazol in Percutaneous Coronary Interventions

Shannon W Finks, K. C. Rogers, J. Faircloth, 2012, The Annals of pharmacotherapy.

Bivalirudin for Patients with Heparin-Induced Thrombocytopenia Undergoing Cardiovascular Surgery

Quinn A. Czosnowski, Shannon W Finks, K. C. Rogers, 2008, The Annals of pharmacotherapy.

Bivalirudin Use in Carotid Endarterectomy in a Patient with Heparin-Induced Thrombocytopenia

Shannon W Finks, Shannon W. Finks, 2006, The Annals of pharmacotherapy.

Assessing the Impact of Comprehensive Medication Management on Achievement of the Quadruple Aim.

Erica F. Crannage, Shannon W Finks, M. McFarland, 2021, The American journal of medicine.

Avoiding patient morbidity: Updated statin drug interactions and risks for patient harm.

Shannon W Finks, Jennifer D. Campbell, Shannon W. Finks, 2014, The Nurse practitioner.

Idarucizumab (Praxbind): The First Reversal Agent for a Direct Oral Anticoagulant.

Shannon W Finks, K. C. Rogers, Shannon W. Finks, 2017, The American journal of medicine.

Job sharing for women pharmacists in academia.

Shannon W Finks, K. C. Rogers, 2009, American journal of pharmaceutical education.

Periprocedural Management of Direct Oral Anticoagulants Surrounding Cardioversion and Invasive Electrophysiological Procedures

P. Dobesh, Shannon W Finks, T. Trujillo, 2018 .

Contemporary Management of Direct Oral Anticoagulants During Cardioversion and Ablation for Nonvalvular Atrial Fibrillation

P. Dobesh, Shannon W Finks, T. Trujillo, 2019, Pharmacotherapy.

Key Articles and Guidelines in the Management of Hypertension

P. Dobesh, Shannon W Finks, K. McConnell, 2015, Journal of pharmacy practice.

Sorting it out: what JNC 8 is and what it is not.

Shannon W Finks, Toni L. Ripley, 2015, Journal of managed care & specialty pharmacy.

Evaluation of bleeding in patients receiving direct oral anticoagulants

Shannon W Finks, K. Faulkenberg, E. Hellenbart, 2017, Vascular health and risk management.

Key Articles of Dietary Interventions that Influence Cardiovascular Mortality

Shannon W Finks, T. Trujillo, S. Chow, 2012, Pharmacotherapy.

Role of the Pharmacist in Achieving Performance Measures to Improve the Prevention and Treatment of Venous Thromboembolism

P. Dobesh, Shannon W Finks, T. Trujillo, 2013, Pharmacotherapy.

Conflict of Interest Disclosures.

Shannon W Finks, 2019, Journal of lower genital tract disease.

The Fall Risk with Alpha blockers Given InitiaL dose or Elderly status (FRAGILE) Study

Shannon W Finks, K. C. Rogers, Sloan M Regen, 2020, The Annals of pharmacotherapy.

An Underappreciated and Prolonged Drug Interaction Leads to Ineffective Anticoagulation

Shannon W Finks, R. Shah, K. C. Rogers, 2019, Southern medical journal.

Medication Optimization: Integration of Comprehensive Medication Management into Practice.

Shannon W Finks, M. McFarland, M. Buck, 2021, American health & drug benefits.

Treating Hypertension in Chronic Obstructive Pulmonary Disease.

Shannon W Finks, T. Self, M. Rumbak, 2020, The New England journal of medicine.

Student Pharmacists’ Perceptions of a Composite Examination in Their First Professional Year

Sharon K. Mcdonough, Shannon W Finks, M. Chisholm-Burns, 2016, American Journal of Pharmaceutical Education.